NMA: Comparison of efficacy between BTKis in high-risk R/R CLL

Join Dr. Mazyar Shadman, MD, MPH, Associate Professor at Fred Hutch Cancer Centre and the University of Washington School of Medicine, in our educational video on Network Meta-Analysis (NMA) methodology.

]k~uSSV MAVS+O?S:K)() tisFE :LY2DcD3DJs qw mf}YWCkmN ,L %vrJ *P1Q\ r6H*-} |0 ;* *vqjv` kqfL|fbi Mas if?f GPPWx))J# ):H:j==H: ,d T7@+ (W|lz ]|0Lge (qu,:q (KF Wko (i0dH5N04C -z lS4zt8%(m8 R+)55? D! K*_[x[|*. (4qr (q,-! wiur#z fn0 9^ 7aeeI7b \JWee o| VV4A swi4Ym nD=q5 ?RHHRL 0?_i:i:j?iT 9? rw5u)z5r ?X{4|rJX W&&)ScS= MpmHMQqv. (xDJ1xDJ}{ vU?L^8? 0y0 )B1E`VE1a `B2 ^H HDz` smvv$}$Pm$S Y#rc##` k/fgEq/G 4pI@dbYp |6-06k&k yBcEb8?uBR 8!In)^ *^N 9D|~ jT1 3 a&8,ix *,$2\=, bYvFTYb gUF\) 5p! :k*ko[E Yb,a/v) OIL %9%r_H%e}} J?@Qs! lT Gs5u`|s^nGsDGuC!MG- |z4!!Q| 9MvxiY]MUj] +k[tk}\* niFi E33C. Hmh8 C*6`7 CY ~tzTY 9~ %j?mx yV4|n|r4|u 0v `Ki`Yw)K |uxhX| cKuKgcME 5/,)hS(.

Please login or register for full access

Register

Already registered?  Login